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Abstract 
INTRODUCTION: Sepsis is the most common cause of acute kidney injury (AKI), and AKI has now been 
described as a major risk factor for chronic kidney disease (CKD). Post-inflammatory renal scarring from the 
activation of nuclear factor-kappaB (NF-kappaB) due to AKI may be an important contributor to CKD 
development. NF-kappaB is a diverse family of transcription factors activated by inhibitor of kappaB kinase 
(IKK). 
 
METHODS: Male Wistar rats underwent a right-hand nephrectomy and unilateral renal ischaemia for 30 
minutes or sham operation (no ischemia) (n = 8). Two groups of animals subject to ischemia reperfusion 
injury (IRI) were administered the IKK inhibitor IKK16 (1 mg/kg i.v. in 10% DMSO) given at 24-h post- 
reperfusion. Control animals were allowed to recover and culled at 1 (n = 4), 2 (n = 4), 3 (n = 4), 7 (n = 4), 14 
(n = 4) or 28 (n = 7) days, and IKK16 treated animals were culled at 2 (n = 4) or 28-days (n = 7). 24-h prior to 
experiment termination, rats were placed into metabolic cages for urine collection. 
 
RESULTS: When compared to sham-operation rats, rats subjected to unilateral renal IRI (control) developed 
AKI. Late administration of IKK16 resulted in a significant improvement in renal function (lower 
creatinine/urea) and structural injury at 48-h post reperfusion. When compared to rats subjected to sham-
operation, control rats demonstrated significant increases in Sirius red staining (indicative of fibrosis) at 28-
days post reperfusion, which was markedly reduced by the late administration of IKK16. 
 
CONCLUSION: The late inhibition of IKK may, therefore, have therapeutic potential in the recovery of AKI 
and the prevention of subsequent CKD. 
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